$RYZ

Ryerson (RYZ) Q1 2026 Earnings Transcript

Ryerson (RYZ) reported Q1 2026 revenue of $1.57 billion (+37.9%) with tons shipped up 31.2% and average selling price up 5.2%. Net income was $4.5 million ($0.10/share); adjusted net income $13.1 million ($0.30). Adjusted EBITDA ex-LIFO rose to $67.4 million. Q2 guidance: net income $20–$22 million and revenue $1.86–$1.93 billion.

Original reporting
Published Jun 1, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 1, 2026, 9:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ryerson (RYZ) Q1 2026 Earnings Transcript — source image
Decision brief

The 30-second read

$RYZBullishHigh
01

Why it matters

The transcript emphasizes improving sequential same-store revenue, margin expansion ex-LIFO, and early procurement synergies, while also flagging leverage deterioration and higher-than-expected LIFO expense as near-term headwinds. Q2 guidance provides a concrete earnings/EBITDA framework for traders to reprice the stock around integration execution and commodity sensitivity.

02

Market read

Concrete Q2 guidance ranges plus leverage and LIFO expense details make this more than a recap; it’s a repricing catalyst for earnings expectations and risk assessment.

03

What to watch

Working-capital cash outflow ($179M) and leverage increase to 5.1x could constrain buyback pace and raise financing sensitivity even with EBITDA growth.

Relevance 9/10Novelty 8/10Timing: After-hours/earnings transcript context ahead of next trading session

Background

Ryerson’s Q1 2026 performance is presented alongside early integration progress from the Olympic Steel acquisition, with LIFO accounting and leverage highlighted as key drivers.

Company-level read

Ticker impact

$RYZBullishHigh confidence
Context

Ryerson reports Q1 results and provides Q2 2026 guidance, including EBITDA ex-LIFO targets and revenue outlook tied to Olympic Steel integration.

Expected impact

Moderate positive bias if investors focus on EBITDA growth and synergy run-rate; downside risk if leverage/LIFO drag dominates.

Evidence & confidence

The article includes specific, decision-relevant datapoints (Q2 guidance ranges, leverage jump to 5.1x, LIFO expense above expectations, and early synergy realization) that directly affect Ryerson’s earnings outlook and risk premium.

Market effects

Metal service center demand signals (ISM-corroborated order activity) and integration-driven margin/EBITDA narrative may influence sentiment across peers.

Primarily North American industrial/materials sentiment via manufacturing activity and OEM contract demand commentary.

Limited direct global linkage; commodity-driven LIFO expense highlights sensitivity to global metal price moves.

Counterpoint

Contract business remains 4%-5% behind, and LIFO expense overshot—synergy may not fully offset margin/risk concerns if commodity prices stay elevated.

Key entities

  • Ryerson Holding Corporation

    Reports Q1 results, integration progress with Olympic Steel, and issues Q2 2026 guidance including adjusted EBITDA ex-LIFO and revenue ranges.

  • Olympic Steel

    Contributes to Ryerson’s consolidated results and synergy targets; its full-period inclusion drives the Q2 outlook.

  • Edward Lehner

    CEO who frames demand/order activity and integration progress during the earnings call.

Related articles

$RYZMedAI 8/10

Ryerson Reports Second Quarter 2026 Results

Ryerson Holding (NYSE:RYZ) reported Q2 2026 results ended June 30, its first full quarter after the Feb 13, 2026 Olympic Steel merger. Revenue was $2.01B, net income $15.5M or $0.30/share, and Adjusted EBITDA ex-LIFO $101.0M. It expects $13-$14M Q3 synergies and $52-$56M annualized run-rate.

$HMNMed

Horace Mann Educators Q2 Earnings Call Highlights

Horace Mann (NYSE:HMN) reported Q2 call highlights. Management said auto frequency and severity trends were favorable and liability losses mid-single digits. It cut its full-year catastrophe-loss assumption to about $75M from $90M, while lowering total net investment income outlook to $465M-$475M. Revenue rose 8% YoY; life sales +20%.

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.